Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +918048034981 (International callers) or 08048034981 (Indian callers).
Dapaworth 10mg tablet (dapagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor primarily used to manage type 2 diabetes by removing excess glucose via urine.
Semasize 1 mg Injection is a prescription medication used for managing type 2 diabetes, obesity, and reducing cardiovascular risks. It is a GLP-1 receptor agonist that acts as a weekly injection, often marketed as a pre-filled, multi-dose disposable pen.
Sembolic 14 mg is a prescription oral medication containing semaglutide, primarily used to manage type 2 diabetes by mimicking the GLP-1 hormone to improve blood sugar control. It is manufactured by Torrent Pharmaceuticals and is often used alongside diet and exercise to lower HbA1c levels.
Semaglutide injection products, primarily branded as Ozempic and Wegovy, are GLP-1 receptor agonists designed for weekly, subcutaneous, self-administered weight management and type 2 diabetes treatment. These products are typically indicated for chronic weight management alongside lifestyle changes, or glycemic control in adults.
Hepaglide 0.5 mg Injection is a prescription medication, commonly used to treat type 2 diabetes and assist in weight management. It contains Semaglutide, a GLP-1 receptor agonist that mimics a natural hormone to regulate blood sugar, decrease appetite, and slow gastric emptying .
Noveltreat 1 mg (Semaglutide) is a prescription-based, once-weekly pre-filled injection pen manufactured by Sun Pharma for weight management and type 2 diabetes treatment. It is a GLP-1 receptor agonist that helps control blood sugar and reduces appetite.
Noveltreat 0.5 mg is a prescription-based, once-weekly injectable medication designed to manage Type 2 diabetes and assist with chronic weight management in adults, often used when diet and exercise are insufficient. It belongs to the GLP-1 receptor agonist class and contains semaglutide, which helps regulate blood sugar by stimulating insulin release, reducing liver sugar production, and slowing gastric emptying to increase feelings of fullness
Extensior 0.5 mg is a prescription-based, once-weekly injection used for managing type 2 diabetes and long-term weight control in adults. It contains the active ingredient semaglutide and is marketed in India through a partnership between Abbott and Novo Nordisk.
Obesema 1 mg Injection is a prescription medication, containing semaglutide, designed for chronic weight management and type 2 diabetes care. It works as a GLP-1 receptor agonist, aiding in appetite reduction and blood sugar regulation, typically administered as a once-weekly, subcutaneous injection
Hepaglide 0.25 mg Injection is a weekly subcutaneous,, prescription-based, semaglutide-based medication used to manage type 2 diabetes, obesity, and weight loss. It is a GLP-1 receptor agonist that acts by lowering blood sugar, slowing digestion, and reducing appetite and typically supplied in a prefilled multi-dose pen with needles.
Endace-160 Tablet contains Megestrol, a Progestogen. Megestrol may work by affecting certain hormones. This may increase appetite, helping with weight loss.
Endace-160 Tablet is used as a symptomatic treatment in patients with breast cancer and endometrial cancer. Breast cancer develops in the breast cells and is characterised by a lump in the breast, a change in the shape of the nipple or breast, and bloody discharge from the nipples.
Endace 40 Tablet is a medicine used for the treatment of anorexia, cachexia, or significant, unexplained weight loss in patients with advanced cancer or acquired immunodeficiency syndrome (AIDS). It helps improve appetite and promote weight gain.